Correlation between α-ketoglutarate and the oxidative stress response in patients with coronary heart disease and prognostic analysis of interventional therapy for coronary heart disease

Correlation between α-ketoglutarate and the oxidative stress response in patients with coronary heart disease and prognostic analysis of interventional therapy for coronary heart disease

ObjectiveTo explore the correlation between α-ketoglutarate and the oxidative stress response in patients with coronary heart disease (CHD) and to analyze the prognosis of CHD patients receiving interventional treatment.MethodsA total of 318 CHD patients admitted from September 2020 to September 202...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huantang Deng, Yu Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	coronary heart disease oxidative stress interventional therapy α-ketoglutarate prognosis assessment
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1544537/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Essential role of the metabolite α-ketoglutarate in bone tissue and bone-related diseases
by: Wu Zuping, et al.
Published: (2025-02-01)

The physiological function of α-ketoglutarate acid and its research advances in stomatology
by: CHENG Chunan, et al.
Published: (2024-06-01)

Dimethyl α-ketoglutarate ameliorates cisplatin-induced acute kidney injury by modulating mitophagy through the PINK1/Parkin pathway
by: Haijing Dou, et al.
Published: (2025-08-01)

INTERRELATION OF TRANSCUTANEOUS CORONARY INTERVENTIONS FOR ACUTE FORMS OF CORONARY HEART DISEASE AND MORTALITY PARAMETERS IN TYUMEN REGION INHABITANTS
by: V. A. Kuznetsov, et al.
Published: (2014-06-01)

HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy
by: Yang Kong, et al.
Published: (2023-01-01)

RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE
by: M. V. Ezhov
Published: (2016-01-01)

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes
by: Ryaan EL‐Andari, et al.
Published: (2025-06-01)

Left Main Coronary Artery Bifurcation Coronary Intervention in a Patient with Achondroplasia with Multivessel Coronary Artery Disease
by: Debasish Das, et al.
Published: (2022-07-01)

Late results of transcutaneous coronary intervention in patients, suffering ischemic heart disease and diabetes mellitus
by: G. B. Mankovsky
Published: (2018-04-01)

DEVELOPING A REGISTER OF OUTCOMES OF CHRONIC CORONARY HEART DISEASE: CHD PROGNOSIS STUDY
by: S. N. Tolpygina, et al.
Published: (2013-02-01)

MOLECULAR AND GENETIC MARKERS FOR CORONARY HEART DISEASE PROGNOSIS IN ELDERLY PATIENTS
by: N. A. Malygina, et al.
Published: (2009-08-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

Endothelial dysfunction and prognosis after coronary interventions in patients with coronary heart disease and arterial hypertension
by: M. V. Kazak, et al.
Published: (2011-10-01)

Characteristics of patients with coronary artery disease and type 2 diabetes mellitus undergoing elective percutaneous coronary intervention
by: Anastasiya G. Neeshpapa, et al.
Published: (2025-01-01)

Predisposition to psychological distress in patients with coronary artery disease and three-year prognosis after coronary artery stenting
by: A. N. Sumin, et al.
Published: (2025-07-01)

Influence of multimorbidity on the risk of events in men with chronic coronary artery disease after myocardial infarction and percutaneous coronary intervention
by: D. V. Dedov, et al.
Published: (2023-12-01)

ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
by: M. G. Glezer, et al.
Published: (2013-10-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
by: K. A. Kireev, et al.
Published: (2015-09-01)

ANTIISCHEMIC METABOLIC MODULATOR TRIMETAZIDINE IN TREATMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2017-02-01)

Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
by: A. V. Svarovskaya, et al.
Published: (2020-07-01)

Microgliosis, neuronal death, minor behavioral abnormalities and reduced endurance performance in alpha-ketoglutarate dehydrogenase complex deficient mice
by: Márton Kokas, et al.
Published: (2025-09-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

Computed tomography angiography or invasive coronary angiography in patients with lowto intermediate risk acute coronary syndrome — a single-center study
by: K. V. Kuznetsova, et al.
Published: (2024-04-01)

CEREBRAL CIRCULATION AND COGNITION IN PATIENTS WITH CORONARY HEART DISEASE UNDERWENT CORONARY BYPASS OPERATION
by: М. М. Petrova, et al.
Published: (2017-03-01)

Prediction value of serum TMAO on myocardial injury after PCI in patients with coronary heart disease based on decision curve analysis
by: CHEN Guixiu，GUO Cheng，HE Lin
Published: (2025-08-01)

Prognostic value of systemic immune-Inflammatory index in patients with diabetes mellitus and acute coronary syndrome after percutaneous coronary intervention: a prospective cohort study
by: Leli Zhang, et al.
Published: (2025-08-01)

Perioperative Hemostatic Features in Patients with Acute Coronary Syndrome and Chronic Coronary Heart Disease
by: Yu. V. Nikiforov, et al.
Published: (2007-08-01)

Coronary Heart Disease in HIV-Infected Patients
by: M. A. Arzhakova, et al.
Published: (2020-01-01)

Diagnostic and prognostic role of PAPP-A and inflammatory markers in various forms of coronary heart disease
by: A. O. Shevchenko, et al.
Published: (2010-06-01)

Combination of coronary heart disease, chronic heart failure, and anaemic syndrome: clinical features and prognostic impact of anaemia treatment
by: T. Yu. Kalyuta, et al.
Published: (2013-04-01)

EARLY DIAGNOSTICS OF HEART FAILURE IN PATIENTS WITH CORONARY HEART DISEASE
by: O. V. Bulashova, et al.
Published: (2003-08-01)

New perspectives in coronary heart disease management
by: V. I. Makolkin
Published: (2005-02-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

Unspecific resistance in patients with coronary heart disease and extrasystolia
by: V. V. Anikin, et al.
Published: (2004-02-01)

Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01)

Electrocardiographic, echocardiographic and lipid parameters in predicting obstructive coronary artery disease in patients with non-ST elevation acute coronary syndrome
by: M. M. Tsivanyuk, et al.
Published: (2022-07-01)

Cardiometabolic risk factors in predicting obstructive coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
by: B. I. Geltser, et al.
Published: (2021-12-01)

Long-term prognosis after acute coronary syndrome due to de novo coronary artery lesions and stent thrombosis in patients on hemodialysis
by: Sho Nakao, et al.
Published: (2025-07-01)